Stock CONTEXT THERAPEUTICS INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Context Therapeutics Inc. Nasdaq

Equities

US21077P1084

Market Closed - Nasdaq
Other stock markets
 21:00:00 16/07/2024 BST 		5-day change 1st Jan Change
2.19 USD -0.45% Intraday chart for Context Therapeutics Inc. +12.89% +93.81%
05-08 Context Therapeutics Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
05-06 Context Therapeutics Inc. announced that it has received $99.992767 million in funding from Ally Bridge Group, Avidity Partners, LLC, Blue Owl Healthcare Opportunities, Deep Track Capital, LP, Driehaus Capital Management LLC, Great Point Partners, LLC CI

Evolution of the average Target Price on Context Therapeutics Inc.

Price target over the last 5 years

History of analyst recommendation changes

576007e058e7.S2EtRw_EXL7IFygLxnE5tlsMdxKhht12vmXx9Plk97U.EglHCU2cGfyXQUNir0gJ4A15RnvCwqoMhjG2wJJSwOMmL2MGafQ_y4pDYQ~b490eff8425c0a4a89b54060c81b3b02

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
Number of Analysts
0
Last Close Price
-
Average target price
-

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions
  1. Stock Market
  2. Equities
  3. Stock
  4. Stock
  5. Consensus Context Therapeutics Inc.